Chinese Biopharaceutical Association Hosts 2010 Chinese New Year Gala in Washington, DC

Share Article

One of the Largest Chinese Professional Organizations in the US Biopharmaceutical Industry Hosts Its Annual Gala to Show Appreciation to Supporters and Sponsors, and to Introduce Its 2010 Annual Conference in the US

"By fostering collaboration among Chinese American professionals in Maryland and across the world, your efforts are helping us pursue the stronger future we all prefer.” Maryland Governor Martin O’Malley

The Chinese Biopharmaceutical Association-USA (CBA) announced today that it is hosting its 2010 Chinese New Year Gala this February 21 at Glenview Mansion at Rockville Civic Center Park, Maryland which is open to all interested parties.

The annual CBA Chinese New Year Gala is one of the most prestigious networking events in the Greater Washington D.C. area. With hundreds of invited attendees, including CEOs of local and international biopharmaceutical companies, entrepreneurs, scientists, venture capitalists, U.S. government officials, and officials from the Chinese Embassy, the 2010 CBA New Year's Gala is a unique networking opportunity for those who are interested in interacting with key personnel in the U.S. and Chinese biopharmaceutical industries.

"By fostering collaboration among Chinese American professionals in Maryland and across the world, your efforts are helping us pursue the stronger future we all prefer.” Maryland Governor Martin O’Malley
In addition, the CBA announced today that its 15th annual conference will be held on June 12-13 at the USM Shady Grove Center, in Rockville, Maryland.

“Over the past decade, the CBA has played an integral role in fostering collaborations among global biopharmaceutical companies, the life sciences and healthcare communities in China. Our goal is to expand our leading role in this effort and enhance the pace of collaboration building through a variety of specially designed activities. CBA’s annual conference is the centerpiece of this effort, said Yifan Zhai, M.D., Ph.D., president of the Chinese Biopharmaceutical Association-USA.

A recent letter addressed to Dr. Yifan Zhai, United States Senator Barbara A. Mikulski says, “Since its inception in 1995, the CBA has been true to its mission to promote science, technology and business development in biopharmaceutical disciplines." And another letter addressed to Gala attendees, Maryland Governor Martin O’Malley says “By fostering collaboration among Chinese American professionals in Maryland and across the world, your efforts are helping us pursue the stronger future we all prefer.”

With its theme of Biopharmaceutical Medicines: Development and Commercialization without Borders, the 15th CBA annual conference includes five sessions:

  •      An Insider’s View of the Current State of Biopharmaceutical Development and Commercialization
  •      Center for Biopharmaceutical R&D – China’s BioIncubator Showcase
  •      Cutting-Edge Pharmaceutical Innovation and Development
  •      Showcase of Drug Development Projects Currently Seeking Infusions of Investment
  •      Pathways to Success in China – A Bird’s-Eye View through Case Studies

In addition to a compelling and timely conference program, the CBA will present its 2010 Brilliant Achievement Award during the Conference, recognizing exemplary accomplishments in the field that promotes collaboration and global development involving the biopharmaceutical sector in China. More than 600 attendees from the US, China, and many other countries are expected to attend.

For more information, please visit http://www.cba-usa.org or e-mail contact(at)cba-usa(dot)org.

About the Chinese Biopharmaceutical Association - USA

The Chinese Biopharmaceutical Association – USA (CBA) is one of the largest Chinese American professional associations in the United States. Founded in 1995, CBA is an independent, non-political, not for-profit professional organization dedicated to fostering global collaboration in biopharmaceutical discovery and development between Chinese organizations and corporations and partners around the world. The Association is led by its elected board of directors and executive committee. For more information about the CBA and its programs, visit http://www.cba-usa.org.

News contact:
Yanni Wang
Vice President for Communications
Chinese Biopharmaceutical Association-USA
(301) 606-1306

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Silas Deane
Visit website